The FDA just approved Viramune (nevirapine)
July 1996
The FDA just approved Viramune (nevirapine)...the FIFTH new antiviral for HIV in just the last 6 months.
It'll be out early next month...from Boehringer Ingelheim.
Viramune is the first drug in a new class called non-nucleoside reverse transcriptase inhibitors. It inhibits the same enzyme as AZT...but it works in a different way.
Get concise advice on drug therapy, plus unlimited access to CE
Pharmacist's Letter membership benefits include:
- 12 issues every year — what you need to know and do, right now
- Quick, practical reference charts and tools
- Comprehensive CE library to meet license renewal and state requirements
- Multiple course formats including live webinars, podcasts, and CE-in-the-Letter to match your learning style
- Plus much more!
Choose the right tier for your needs today.
Already a subscriber? Log in
Volume pricing available. Get a quote